Your browser doesn't support javascript.
loading
A real or apparent decrease in glomerular filtration rate in patients using olaparib?
Bruin, M A C; Korse, C M; van Wijnen, B; de Jong, V M T; Linn, S C; van Triest, B; Rosing, H; Beijnen, J H; van den Broek, D; Huitema, A D R.
Affiliation
  • Bruin MAC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. ma.bruin@nki.nl.
  • Korse CM; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Wijnen B; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • de Jong VMT; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Linn SC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Triest B; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Rosing H; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • van den Broek D; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Huitema ADR; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Eur J Clin Pharmacol ; 77(2): 179-188, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33319340

Full text: 1 Database: MEDLINE Main subject: Phthalazines / Piperazines / Poly(ADP-ribose) Polymerase Inhibitors / Glomerular Filtration Rate / Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Phthalazines / Piperazines / Poly(ADP-ribose) Polymerase Inhibitors / Glomerular Filtration Rate / Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2021 Type: Article